Tapewire

Nasdaq · USD

RPRX

Royalty Pharma plc

Export transactions ↓
Tapewire entity
3100
SEC CIK
0001802768
Parsed reports
338

Last 12 months

Inside the activity.

0 purchase rows · 74 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 2025014
Dec 2025014
Jan 202609
Feb 202608
Mar 202606
Apr 202604
May 202604
Jun 202607
Jul 202601
Aug 202603
Sep 202603
Oct 202601

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
June 30, 2022 Filed Jun 30, 2022 10:55 UTC GrantClass A Ordinary Shares 903 $41.52 $37,492.83
Disclosure

SEC source: 0001209191-22-039877 · doc4.xml · nonDerivative · entry 1

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,925

F1 · price: Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.

Read SEC document
June 30, 2022 Filed Jun 30, 2022 10:51 UTC GrantClass A Ordinary Shares 903 $41.52 $37,492.83
Disclosure

SEC source: 0001209191-22-039876 · doc4.xml · nonDerivative · entry 1

Fernandez Henry A · CIK 0001416750 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 26,131

F1 · price: Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.

Read SEC document
June 29, 2022 Filed Jun 29, 2022 22:02 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 30,000 $42.17 $1,265,238.00
Disclosure

SEC source: 0001209191-22-039839 · doc4.xml · nonDerivative · entry 1

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 421,712

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.05 to $42.29 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 24, 2022 Filed Jun 24, 2022 20:59 UTC GrantClass A Ordinary Shares 6,328 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-024044 · doc4.xml · nonDerivative · entry 1

Engelbert Catherine M. · CIK 0001796439 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,464

F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

Read SEC document
June 24, 2022 Filed Jun 24, 2022 20:53 UTC GrantClass A Ordinary Shares 6,328 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-024036 · doc4.xml · nonDerivative · entry 1

HODGSON DAVID C · CIK 0001193346 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,328

F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

Read SEC document
June 24, 2022 Filed Jun 24, 2022 21:19 UTC
Urist MarshallEVP, Research & Investments
SaleClass A Ordinary Shares 23,333 $43.19 $1,007,693.94
Disclosure

SEC source: 0001209191-22-039294 · doc4.xml · nonDerivative · entry 1

Urist Marshall · CIK 0001838139 · EVP, Research & Investments

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,334

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $43.11 to $43.27 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
June 24, 2022 Filed Jun 24, 2022 20:59 UTC GrantClass A Ordinary Shares 6,328 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-024045 · doc4.xml · nonDerivative · entry 1

Norden Gregory · CIK 0001405104 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,698

F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

Read SEC document
June 24, 2022 Filed Jun 24, 2022 20:57 UTC GrantClass A Ordinary Shares 6,328 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-024042 · doc4.xml · nonDerivative · entry 1

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 31,022

F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

Read SEC document
June 24, 2022 Filed Jun 24, 2022 20:57 UTC
LOVE TED WDirector
GrantClass A Ordinary Shares 6,328 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-024040 · doc4.xml · nonDerivative · entry 1

LOVE TED W · CIK 0001188919 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 29,194

F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

Read SEC document
June 24, 2022 Filed Jun 24, 2022 20:55 UTC GrantClass A Ordinary Shares 6,328 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-024038 · doc4.xml · nonDerivative · entry 1

DESOUZA ERROL B · CIK 0001213895 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,698

F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

Read SEC document
June 24, 2022 Filed Jun 24, 2022 20:49 UTC GrantClass A Ordinary Shares 6,328 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-024032 · doc4.xml · nonDerivative · entry 1

Fernandez Henry A · CIK 0001416750 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,228

F1 · shares: Reflects an award of restricted stock units under the Issuer's 2020 Independent Director Equity Incentive Plan (the "Plan") that is generally scheduled to vest 100% on the earlier of (i) the one-year anniversary of the grant date and (ii) the date of the annual meeting of the Issuer's shareholders in the first calendar year following the grant date, subject to the terms of the Plan and the applicable award agreement thereunder.

Read SEC document
June 08, 2022 Filed Jun 10, 2022 21:13 UTC
Reddoch James F.EVP & Chief Scientific Officer
SaleClass A Ordinary Shares 100,000 $41.56 $4,155,900.00
Disclosure

SEC source: 0000899243-22-021954 · doc4.xml · nonDerivative · entry 1

Reddoch James F. · CIK 0001814872 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Reddoch RPI LLC

Disclosed balance after: 920,800

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $41.37 to $41.73 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 27, 2022 Filed May 31, 2022 17:19 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 13,974 $40.77 $569,753.52
Disclosure

SEC source: 0001209191-22-032900 · doc4.xml · nonDerivative · entry 2

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2014 G, LLC

Disclosed balance after: 430,000

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.67 to $40.89 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 27, 2022 Filed May 31, 2022 21:23 UTC
Reddoch James F.EVP & Chief Scientific Officer
SaleClass A Ordinary Shares 75,000 $41.08 $3,081,007.50
Disclosure

SEC source: 0001209191-22-032906 · doc4.xml · nonDerivative · entry 1

Reddoch James F. · CIK 0001814872 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Reddoch RPI LLC

Disclosed balance after: 1,020,800

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.97 to $41.16 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 26, 2022 Filed May 31, 2022 17:19 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 86,026 $40.21 $3,459,337.73
Disclosure

SEC source: 0001209191-22-032900 · doc4.xml · nonDerivative · entry 1

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2014 G, LLC

Disclosed balance after: 443,974

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.26 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 23, 2022 Filed May 25, 2022 17:10 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 100,000 $40.27 $4,026,770.00
Disclosure

SEC source: 0001209191-22-031924 · doc4.xml · nonDerivative · entry 1

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2014 G, LLC

Disclosed balance after: 530,000

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.80 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 20, 2022 Filed May 23, 2022 20:55 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 123,696 $39.28 $4,858,655.18
Disclosure

SEC source: 0001209191-22-031363 · doc4.xml · nonDerivative · entry 2

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 451,712

F2 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.00 to $40.04 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 19, 2022 Filed May 23, 2022 20:55 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 26,304 $40.09 $1,054,650.99
Disclosure

SEC source: 0001209191-22-031363 · doc4.xml · nonDerivative · entry 1

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 575,408

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.00 to $40.29 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 19, 2022 Filed May 23, 2022 20:57 UTC
Reddoch James F.EVP & Chief Scientific Officer
SaleClass A Ordinary Shares 75,000 $40.44 $3,033,127.50
Disclosure

SEC source: 0001209191-22-031366 · doc4.xml · nonDerivative · entry 1

Reddoch James F. · CIK 0001814872 · EVP & Chief Scientific Officer

10b5-1 filing: Not disclosed

Ownership: Indirect · By Reddoch RPI LLC

Disclosed balance after: 1,095,800

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.35 to $40.60 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 16, 2022 Filed May 16, 2022 23:14 UTC
Urist MarshallEVP, Research & Investments
SaleClass A Ordinary Shares 23,333 $39.85 $929,836.38
Disclosure

SEC source: 0000899243-22-018222 · doc4.xml · nonDerivative · entry 1

Urist Marshall · CIK 0001838139 · EVP, Research & Investments

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 46,667

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.57 to $40.09 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
May 11, 2022 Filed May 11, 2022 21:20 UTC
Urist MarshallEVP, Research & Investments
ConversionLP interests in RPI US Partners 2019, LP · Derivative 7,000 $0.00 Strike: $0.00 $0.00
Disclosure

SEC source: 0000899243-22-017656 · doc4.xml · derivative · entry 3

Urist Marshall · CIK 0001838139 · EVP, Research & Investments

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 205,594

Underlying: Class A Ordinary Shares · 70,000 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.

F2 · derivative.exercise_date: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.

F2 · derivative.expiration_date: Represents RPI US LP Interests. Each RPI US LP Interest can be exchanged for ten Class B Interests in Holdings at any time and for no additional value, which exchange right does not expire until so converted. Upon such exchange, each Class B Interest in Holdings issued in exchange for a RPI US LP Interest will be exchanged for one Class A Ordinary Share of the Issuer for no additional value.

F3 · balance_after: The Reporting Person has agreed to retain and not sell 198,594 RPI US LP Interests convertible into 1,985,940 Class A Ordinary Shares before February 2025 pursuant to an agreement by and between the Reporting Person and RP Management, LLC. This restriction is waivable under certain circumstances.

Read SEC document
May 11, 2022 Filed May 11, 2022 21:20 UTC
Urist MarshallEVP, Research & Investments
ConversionClass A Ordinary Shares 70,000 $0.00 $0.00
Disclosure

SEC source: 0000899243-22-017656 · doc4.xml · nonDerivative · entry 1

Urist Marshall · CIK 0001838139 · EVP, Research & Investments

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 70,000

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · kind: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.

F1 · price: These Class A Ordinary Shares will be received by the Reporting Person in exchange for limited partnership interests in RPI US Partners 2019, LP ("RPI US LP"). Each limited partnership interest in RPI US LP ("RPI US LP Interest") will be exchanged for ten Class B Interests in Royalty Pharma Holdings Limited ("Holdings"). Each Class B Interest in Holdings so distributed will be exchanged for one Class A Ordinary Share of the Issuer. This exchange will be made pursuant to the terms of the Exchange Agreement dated June 16, 2020, among the Issuer, Holdings, RPI US LP, RPI International Holdings 2019, LP, RPI International Partners 2019, LP and RPI EPA Holdings, LP (the "Exchange Agreement"). No additional value will be paid by the Reporting Person in connection with the exchange.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 22:55 UTC
Legorreta Pablo G.Director · CEO, Chairman of the Board · 10% owner
OtherClass A Ordinary Shares 350,000 $0.00 $0.00
Disclosure

SEC source: 0000950103-22-006475 · dp171092_4-legoretta.xml · nonDerivative · entry 4

Legorreta Pablo G. · CIK 0001507678 · Director · CEO, Chairman of the Board · 10% owner

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 63,795

F5 · kind: Represents the transfer by the Reporting Person of Class A ordinary shares for no consideration to RP Management Equity Incentive Plan Trust.

F4 · balance_after: Reflects shares received in exempt pro rata distribution pursuant to Rule 16a-9(a) from Legorreta Investments II LLC, 413,795 Class A ordinary shares to the Reporting Person directly, 6,930 Class A ordinary shares to the Reporting Person's spouse and 41,306 Class A ordinary shares to the GST-Exempt 2020 Family Trust.

Read SEC document
April 14, 2022 Filed Apr 15, 2022 22:55 UTC
Legorreta Pablo G.Director · CEO, Chairman of the Board · 10% owner
OtherClass A Ordinary Shares 462,031 $0.00 $0.00
Disclosure

SEC source: 0000950103-22-006475 · dp171092_4-legoretta.xml · nonDerivative · entry 3

Legorreta Pablo G. · CIK 0001507678 · Director · CEO, Chairman of the Board · 10% owner

10b5-1 filing: Not disclosed

Ownership: Indirect · By Legorreta Investments II LLC

Disclosed balance after: 0

F2 · kind: Reflects the pro rata distribution from Legorreta Investments II LLC to their respective members for no consideration.

F3 · balance_after: Reflects the exempt transfer pursuant to Rule 16a-13 of certain ICAI Interests, RPI US LP Interests and Class A Ordinary Shares from Legorreta Investments LLC to Legorreta Investments II LLC. As of the filing date, Legorreta Investments LLC has 811,759 ICAI Interests and 460,139 Class A Ordinary Shares.

Read SEC document
March 31, 2022 Filed Apr 1, 2022 22:29 UTC GrantClass A Ordinary Shares 964 $38.87 $37,470.97
Disclosure

SEC source: 0001209191-22-022058 · doc4.xml · nonDerivative · entry 1

Fernandez Henry A · CIK 0001416750 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 18,900

F1 · price: Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.

Read SEC document
March 31, 2022 Filed Apr 1, 2022 22:26 UTC GrantClass A Ordinary Shares 964 $38.87 $37,470.97
Disclosure

SEC source: 0001209191-22-022055 · doc4.xml · nonDerivative · entry 1

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 24,694

F1 · price: Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.

Read SEC document
March 29, 2022 Filed Mar 30, 2022 22:46 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 60,000 $38.59 $2,315,322.00
Disclosure

SEC source: 0001209191-22-021660 · doc4.xml · nonDerivative · entry 1

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 601,712

F1 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.51 to $38.74 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 21, 2022 Filed Mar 21, 2022 22:20 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 14,322 $39.05 $559,288.42
Disclosure

SEC source: 0001209191-22-020333 · doc4.xml · nonDerivative · entry 10

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures I LLC

Disclosed balance after: 0

F9 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.71 to $39.30 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 21, 2022 Filed Mar 21, 2022 22:20 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 25,545 $39.05 $997,557.80
Disclosure

SEC source: 0001209191-22-020333 · doc4.xml · nonDerivative · entry 9

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures Select

Disclosed balance after: 0

F9 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $38.71 to $39.30 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 18, 2022 Filed Mar 21, 2022 22:20 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 56,181 $39.77 $2,234,093.65
Disclosure

SEC source: 0001209191-22-020333 · doc4.xml · nonDerivative · entry 8

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures III LLC

Disclosed balance after: 85,187

F8 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.21 to $39.71 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 18, 2022 Filed Mar 21, 2022 22:20 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 26,238 $39.38 $1,033,333.78
Disclosure

SEC source: 0001209191-22-020333 · doc4.xml · nonDerivative · entry 7

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures I LLC

Disclosed balance after: 14,322

F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.20 to $39.70 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 18, 2022 Filed Mar 21, 2022 22:20 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 46,803 $39.38 $1,843,247.23
Disclosure

SEC source: 0001209191-22-020333 · doc4.xml · nonDerivative · entry 6

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures Select

Disclosed balance after: 25,545

F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.20 to $39.70 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
March 17, 2022 Filed Mar 21, 2022 22:20 UTC
RIGGS RORY BDirector
OtherClass A Ordinary Shares 531,684 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-020333 · doc4.xml · nonDerivative · entry 5

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures III LLC

Disclosed balance after: 141,368

F6 · kind: New Ventures III LLC distributed these shares to its members on a pro rata basis, for no consideration.

F6 · price: New Ventures III LLC distributed these shares to its members on a pro rata basis, for no consideration.

Read SEC document
March 17, 2022 Filed Mar 21, 2022 22:20 UTC
RIGGS RORY BDirector
OtherClass A Ordinary Shares 1,075,178 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-020333 · doc4.xml · nonDerivative · entry 4

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures I LLC

Disclosed balance after: 40,560

F5 · kind: New Ventures I LLC distributed these shares to its members on a pro rata basis, for no consideration.

F5 · price: New Ventures I LLC distributed these shares to its members on a pro rata basis, for no consideration.

Read SEC document
March 17, 2022 Filed Mar 21, 2022 22:20 UTC
RIGGS RORY BDirector
OtherClass A Ordinary Shares 229,626 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-020333 · doc4.xml · nonDerivative · entry 3

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures Select

Disclosed balance after: 72,348

F4 · kind: New Ventures Select distributed these shares to its members on a pro rata basis, for no consideration.

F4 · price: New Ventures Select distributed these shares to its members on a pro rata basis, for no consideration.

Read SEC document
March 17, 2022 Filed Mar 21, 2022 22:20 UTC
RIGGS RORY BDirector
OtherClass A Ordinary Shares 64,067 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-020333 · doc4.xml · nonDerivative · entry 2

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 661,712

F3 · kind: Pro rata distribution from New Ventures I LLC, of which the Reporting Person has voting and investment control.

F2 · price: Pro rata distribution from a limited liability company of which the Reporting Person is a member.

Read SEC document
March 17, 2022 Filed Mar 21, 2022 22:20 UTC
RIGGS RORY BDirector
OtherClass A Ordinary Shares 4,897 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-22-020333 · doc4.xml · nonDerivative · entry 1

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 597,645

F1 · kind: Pro rata distribution from New Ventures Select, of which the Reporting Person has voting and investment control.

F2 · price: Pro rata distribution from a limited liability company of which the Reporting Person is a member.

Read SEC document
February 24, 2022 Filed Feb 26, 2022 00:21 UTC PurchaseClass A Ordinary Shares 32,500 $37.49 $1,218,373.00
Disclosure

SEC source: 0001209191-22-013383 · doc4.xml · nonDerivative · entry 1

Fernandez Henry A · CIK 0001416750 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By Fernandez 2007 Children's Trust

Disclosed balance after: 58,200

F1 · price: The price reported in Column 4 is a weighted average price. The reported securities were purchased in multiple transactions at prices ranging from $37.16 to $37.75. The reporting person undertakes to provide to the issuer, any security holder of the issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within such range.

Read SEC document
December 31, 2021 Filed Jan 3, 2022 22:35 UTC GrantClass A Ordinary Shares 958 $39.11 $37,462.69
Disclosure

SEC source: 0001209191-22-000300 · doc4.xml · nonDerivative · entry 1

Fernandez Henry A · CIK 0001416750 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,936

F1 · price: Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.

Read SEC document
December 31, 2021 Filed Jan 3, 2022 22:29 UTC GrantClass A Ordinary Shares 958 $39.11 $37,462.69
Disclosure

SEC source: 0001209191-22-000287 · doc4.xml · nonDerivative · entry 1

Bassler Bonnie L · CIK 0001683607 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 23,730

F1 · price: Reflects Class A Ordinary Shares issued to the reporting person under the Issuer's 2020 Independent Director Equity Incentive Plan in lieu of a quarterly retainer payment of $37,500.

Read SEC document
December 29, 2021 Filed Dec 30, 2021 23:07 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 75,000 $40.00 $3,000,352.50
Disclosure

SEC source: 0001209191-21-071640 · doc4.xml · nonDerivative · entry 9

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 592,748

F9 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $39.85 to $40.29 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
December 28, 2021 Filed Dec 30, 2021 23:07 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 35,193 $40.21 $1,414,962.72
Disclosure

SEC source: 0001209191-21-071640 · doc4.xml · nonDerivative · entry 8

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures III LLC

Disclosed balance after: 673,052

F8 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.02 to $40.57 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
December 28, 2021 Filed Dec 30, 2021 23:07 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 26,677 $40.21 $1,072,559.46
Disclosure

SEC source: 0001209191-21-071640 · doc4.xml · nonDerivative · entry 7

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures I LLC

Disclosed balance after: 1,115,738

F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.05 to $40.57 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
December 28, 2021 Filed Dec 30, 2021 23:07 UTC
RIGGS RORY BDirector
SaleClass A Ordinary Shares 47,578 $40.21 $1,912,892.52
Disclosure

SEC source: 0001209191-21-071640 · doc4.xml · nonDerivative · entry 6

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures Select

Disclosed balance after: 301,974

F7 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $40.05 to $40.57 per share. The holder undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document
December 28, 2021 Filed Dec 30, 2021 23:07 UTC
RIGGS RORY BDirector
OtherClass A Ordinary Shares 407,400 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071640 · doc4.xml · nonDerivative · entry 5

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures III LLC

Disclosed balance after: 708,245

F6 · kind: New Ventures III LLC distributed these shares to its members on a pro rata basis, for no consideration.

F6 · price: New Ventures III LLC distributed these shares to its members on a pro rata basis, for no consideration.

Read SEC document
December 28, 2021 Filed Dec 30, 2021 23:07 UTC
RIGGS RORY BDirector
OtherClass A Ordinary Shares 707,155 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071640 · doc4.xml · nonDerivative · entry 4

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures I LLC

Disclosed balance after: 1,142,415

F5 · kind: New Ventures I LLC distributed these shares to its members on a pro rata basis, for no consideration.

F5 · price: New Ventures I LLC distributed these shares to its members on a pro rata basis, for no consideration.

Read SEC document
December 28, 2021 Filed Dec 30, 2021 23:07 UTC
RIGGS RORY BDirector
OtherClass A Ordinary Shares 150,997 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071640 · doc4.xml · nonDerivative · entry 3

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Indirect · By New Ventures Select

Disclosed balance after: 349,552

F4 · kind: New Ventures Select distributed these shares to its members on a pro rata basis, for no consideration.

F4 · price: New Ventures Select distributed these shares to its members on a pro rata basis, for no consideration.

Read SEC document
December 28, 2021 Filed Dec 30, 2021 23:07 UTC
RIGGS RORY BDirector
OtherClass A Ordinary Shares 42,138 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071640 · doc4.xml · nonDerivative · entry 2

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 667,748

F3 · kind: Pro rata distribution from New Ventures I LLC, of which the Reporting Person has voting and investment control.

F2 · price: Pro rata distribution from a limited liability company of which the Reporting Person is a member.

Read SEC document
December 28, 2021 Filed Dec 30, 2021 23:07 UTC
RIGGS RORY BDirector
OtherClass A Ordinary Shares 3,212 Not disclosed Not disclosed
Disclosure

SEC source: 0001209191-21-071640 · doc4.xml · nonDerivative · entry 1

RIGGS RORY B · CIK 0001016835 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 625,610

F1 · kind: Pro rata distribution from New Ventures Select, of which the Reporting Person has voting and investment control.

F2 · price: Pro rata distribution from a limited liability company of which the Reporting Person is a member.

Read SEC document
November 17, 2021 Filed Nov 18, 2021 19:18 UTC
Lloyd George W.EVP, Investments & GC
SaleClass A Ordinary Shares 84,148 $42.39 $3,566,831.76
Disclosure

SEC source: 0001209191-21-065639 · doc4.xml · nonDerivative · entry 4

Lloyd George W. · CIK 0001814899 · EVP, Investments & GC

10b5-1 filing: Not disclosed

Ownership: Indirect · By GWL 2014 G, LLC

Disclosed balance after: 630,000

F4 · price: The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $42.00 to $42.92 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.